Cresset Asset Management LLC trimmed its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 24.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 375,982 shares of the company's stock after selling 119,918 shares during the quarter. Cresset Asset Management LLC's holdings in Kenvue were worth $8,027,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Principal Financial Group Inc. grew its holdings in shares of Kenvue by 3.2% during the third quarter. Principal Financial Group Inc. now owns 2,364,451 shares of the company's stock valued at $54,690,000 after buying an additional 73,542 shares during the last quarter. Fulton Bank N.A. lifted its position in Kenvue by 7.3% in the 4th quarter. Fulton Bank N.A. now owns 78,423 shares of the company's stock valued at $1,674,000 after acquiring an additional 5,329 shares in the last quarter. Farmers Trust Co. boosted its stake in Kenvue by 1.8% during the 4th quarter. Farmers Trust Co. now owns 217,218 shares of the company's stock valued at $4,638,000 after purchasing an additional 3,767 shares during the last quarter. First Hawaiian Bank increased its holdings in shares of Kenvue by 36.6% in the 4th quarter. First Hawaiian Bank now owns 26,095 shares of the company's stock worth $557,000 after purchasing an additional 6,997 shares in the last quarter. Finally, Fortitude Family Office LLC raised its stake in shares of Kenvue by 106.6% in the fourth quarter. Fortitude Family Office LLC now owns 1,506 shares of the company's stock worth $32,000 after purchasing an additional 777 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
KVUE has been the topic of several recent analyst reports. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Citigroup raised their price target on shares of Kenvue from $21.00 to $22.00 and gave the company a "neutral" rating in a report on Monday, April 14th. Piper Sandler increased their price objective on shares of Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research report on Monday, February 24th. Evercore ISI initiated coverage on shares of Kenvue in a report on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Finally, Redburn Atlantic initiated coverage on shares of Kenvue in a research note on Thursday, April 10th. They set a "neutral" rating and a $23.50 target price for the company. Eight investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Kenvue has an average rating of "Hold" and an average price target of $24.42.
Read Our Latest Research Report on Kenvue
Kenvue Stock Performance
Shares of KVUE opened at $23.03 on Thursday. The business has a 50-day simple moving average of $23.10 and a two-hundred day simple moving average of $22.54. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46. The stock has a market cap of $44.19 billion, a price-to-earnings ratio of 43.45, a PEG ratio of 2.62 and a beta of 1.02.
Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.
Kenvue Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.56%. Kenvue's payout ratio is 154.72%.
Kenvue Profile
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
